Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results for 2024
Toronto, Ontario--(Newsfile Corp. - September 2, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased...
Day: September 2, 2024
Health Kiosk Market Surges to USD 3.29 Billion by 2030, Propelled by 12.17% CAGR – Verified Market Reports®
The global Health Kiosk Market is driven by a combination of technological advancements, increasing healthcare awareness, and the rising demand...
Referral Management Market is expected to generate a revenue of USD 13.48 Billion by 2031, Globally, at 15.8% CAGR: Verified Market Research®
The Referral Management Market is driven by the increasing demand for coordinated patient care, the rising adoption of digital healthcare...
Seegene and Springer Nature Launch ‘Nature Awards MDx Impact Grants’ to Innovate Syndromic PCR Diagnostic Assays
- Nature Awards MDx Impact Grants in partnership with Seegene extends commitment to external innovation.- Global research teams invited to...
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor
NANJING, China, Sept. 2, 2024 /PRNewswire/ -- On September 02, 2024, Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group...
Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
CAMBRIDGE, MA / ACCESSWIRE / September 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug...
ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical’s DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of Action
ESC Congress 2024: INFINITY-SWEDEHEART Trial of Elixir Medical’s DynamX Bioadaptor Meets Primary Endpoint and Clinical Results Confirm Unique Mechanism of...
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
CDX Development Update LONDON, UNITED KINGDOM / ACCESSWIRE / September 2, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO)("Hemogenyx Pharmaceuticals" or the...
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024
GENEVA, SWITZERLAND / ACCESSWIRE / September 2, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical...
Cosmo Pharmaceuticals Highlights Study Published in “The Lancet” Demonstrating the Efficacy of GI Genius(TM) in Colonoscopy Procedures
Dublin, Ireland--(Newsfile Corp. - September 2, 2024) - Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V....
OrionStar Robotics Launches CarryBot: The World’s First Logistics Robot for Micro-Fulfillment Centers
BEIJING, Sept. 1, 2024 /PRNewswire/ -- OrionStar Robotics, the global innovator in service robot applications, has launched CarryBot, the world's...